Fernando Catrambone

Title: Innovations of Fernando Catrambone in Pharmaceutical Chemistry

Introduction

Fernando Catrambone is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of bradykinin antagonists. His work focuses on creating novel compounds that can be utilized in various medical applications.

Latest Patents

Catrambone holds a patent for "Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom." This patent describes non-peptide compounds characterized by the presence of an alpha, alpha-disubstituted amino acid with at least one amino group, which can be free or salified, or the corresponding ammonium quaternary salt. These compounds act as specific antagonists of the bradykinin (BK) B2 receptor, representing a new class of medicaments for treating disorders associated with these receptors.

Career Highlights

Fernando Catrambone is associated with Menarini Ricerche S.p.a., where he continues to innovate in the pharmaceutical sector. His research and development efforts have led to advancements in therapeutic options for various medical conditions.

Collaborations

Catrambone collaborates with esteemed colleagues, including Federico Calvani and Patrizia Felicetti. Their combined expertise enhances the research and development initiatives at Menarini Ricerche S.p.a.

Conclusion

Fernando Catrambone's contributions to pharmaceutical chemistry, particularly through his patent on bradykinin antagonists, highlight his role as an influential inventor in the field. His ongoing work promises to advance medical treatments and improve patient outcomes.